By week four, most patients report that their side effects have diminished significantly, though mild nausea or occasional digestive changes may persist
Additionally, GLP-1 medications can affect gut motility throughout the entire digestive system, not just the stomach
Heres the breakdown: TRICARE will continue to cover medications like Ozempic, Mounjaro, or Victoza but only when prescribed for Type 2 Diabetes , not for weight management
Refining Results After Weight Loss GLP-1/GIP medications like Semaglutide and Tirzepatide often lead to significant weight reduction but some patients are left with stubborn fat pockets or mild skin laxity
Support for Liver and Metabolic Health Fat accumulation in the liver is a common issue in people with long-term metabolic imbalance
Wang WM, Wang X, Duan N, et al